Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
CytomX Therapeutics
CTMX
$732M
| $2.39M | ﹤0.01% |
895,900
+390,400
| +77% | +$1.5M |
|
2102
Freshpet
FRPT
$3.5B
| $2.39M | ﹤0.01% |
23,296
-169,700
| -88% | -$16M |
|
2103
Riverview Bancorp
RVSB
$106M
| $2.39M | ﹤0.01% |
316,607
-62,302
| -16% | -$477K |
|
2104
Neurogene
NGNE
$723M
| $2.39M | ﹤0.01% |
63,448
+21,267
| +50% | +$1.24M |
|
2105
Radcom
RDCM
$176M
| $2.39M | ﹤0.01% |
183,833
+400
| +0.2% | +$4.75K |
|
|
BHR
2106
Braemar Hotels & Resorts
BHR
$139M
| $2.38M | ﹤0.01% |
385,011
+239,311
| +164% | +$1.37M |
|
|
EB
2107
DELISTED
Eventbrite
EB
| $2.38M | ﹤0.01% |
160,900
+100,500
| +166% | +$1.49M |
|
|
STEL
2108
DELISTED
Stellar Bancorp
STEL
| $2.38M | ﹤0.01% |
76,610
-46,600
| -38% | -$1.42M |
|
2109
Verastem
VSTM
$596M
| $2.38M | ﹤0.01% |
140,342
+91,984
| +190% | +$1.58M |
|
|
NGM
2110
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.37M | ﹤0.01% |
155,700
+81,000
| +108% | +$1.26M |
|
2111
NETGEAR
NTGR
$656M
| $2.37M | ﹤0.01% |
96,100
-110,200
| -53% | -$2.94M |
|
2112
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $2.37M | ﹤0.01% |
18,500
+900
| +5% | +$114K |
|
2113
Seer Inc
SEER
$115M
| $2.37M | ﹤0.01% |
155,500
+78,901
| +103% | +$1.22M |
|
|
WHWK
2114
Whitehawk Therapeutics
WHWK
$254M
| $2.37M | ﹤0.01% |
139,522
+11,000
| +9% | +$211K |
|
2115
Altimmune
ALT
$572M
| $2.37M | ﹤0.01% |
388,700
+321,900
| +482% | +$2.37M |
|
2116
NetSol Technologies
NTWK
$48.3M
| $2.37M | ﹤0.01% |
614,165
-53,536
| -8% | -$214K |
|
|
ARIS
2117
DELISTED
Aris Water Solutions
ARIS
| $2.36M | ﹤0.01% |
+129,800
| New | +$1.88M |
|
|
PMD
2118
DELISTED
Psychemedics Corporation
PMD
| $2.36M | ﹤0.01% |
341,422
-30,724
| -8% | -$217K |
|
|
SAFE
2119
Safehold
SAFE
$1.08B
| $2.35M | ﹤0.01% |
+20,667
| New | +$2.42M |
|
2120
ARS Pharmaceuticals
SPRY
$561M
| $2.35M | ﹤0.01% |
670,542
+302,542
| +82% | +$1.32M |
|
2121
LegalZoom.com
LZ
$963M
| $2.35M | ﹤0.01% |
166,200
+124,400
| +298% | +$1.87M |
|
2122
Everspin Technologies
MRAM
$460M
| $2.35M | ﹤0.01% |
269,806
+6,300
| +2% | +$60.3K |
|
|
DHC
2123
Diversified Healthcare Trust
DHC
$2.03B
| $2.35M | ﹤0.01% |
+733,200
| New | +$2.24M |
|
|
DRRX
2124
DELISTED
DURECT Corp
DRRX
| $2.35M | ﹤0.01% |
350,028
+58,885
| +20% | +$409K |
|
2125
Pearson
PSO
$9.72B
| $2.34M | ﹤0.01% |
234,800
-31,744
| -12% | -$287K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 821 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 821 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.